NCT06041789View on ClinicalTrials.gov

Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

PHASE2RecruitingINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions

Osteoporosis

Interventions

DRUG

Donepezil

10 mg tablet

DRUG

Memantine

10 mg tablet

Trial Locations (1)

27705

RECRUITING

Duke Memory Disorders Clinic, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

Duke University

OTHER

NCT06041789 - Effect of Acetylcholinesterase Inhibitors on Bone Metabolism | Biotech Hunter | Biotech Hunter